PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 11410120

  • 1. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
    Peverill RE, Teede HJ, Smolich JJ, Malan E, Kotsopoulos D, Tipping PG, McGrath BP.
    Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
    [Abstract] [Full Text] [Related]

  • 2. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 3. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Feb; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 4. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 5. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
    Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM.
    Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
    [Abstract] [Full Text] [Related]

  • 6. Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?
    McKenzie J, Jaap AJ, Gallacher S, Kelly A, Crawford L, Greer IA, Rumley A, Petrie JR, Lowe GD, Paterson K, Sattar N.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):682-9. PubMed ID: 14974908
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
    Berrettini M, Parise P, Ricotta S, Iorio A, Peirone C, Nenci GG.
    Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
    [Abstract] [Full Text] [Related]

  • 8. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 10. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
    Caserta L, Caserta R, Torella M, Perricone F, Nesti E, Sessa M, Tagliaferri A, De Francesco F, De Lucia D, Panariello S.
    Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 12. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 13. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
    Sørensen MB, Rosenfalck AM, Højgaard L, Ottesen B.
    Obes Res; 2001 Oct; 9(10):622-6. PubMed ID: 11595778
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women.
    Teede HJ, McGrath BP, Turner A, Majewski H.
    Clin Sci (Lond); 2001 Feb; 100(2):207-13. PubMed ID: 11171290
    [Abstract] [Full Text] [Related]

  • 15. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T, Gando S, Kemmotsu O, Mashio H, Goda Y, Kawahigashi H, Watanabe N.
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [Abstract] [Full Text] [Related]

  • 16. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
    Thunell L, Andersson B, Glassell M, Mattsson LA.
    Maturitas; 2006 Mar 20; 53(4):430-8. PubMed ID: 16198072
    [Abstract] [Full Text] [Related]

  • 17. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 18. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
    Sgarabotto M, Baldini M, Dei Cas A, Manotti C, Luciana Barilli A, Rinaldi M, Benassi L, Bacchi Modena A.
    Thromb Res; 2007 Jan 20; 119(1):85-91. PubMed ID: 16499954
    [Abstract] [Full Text] [Related]

  • 19. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
    Agledahl I, Brodin E, Svartberg J, Hansen JB.
    Thromb Haemost; 2009 Nov 20; 102(5):945-50. PubMed ID: 19888533
    [Abstract] [Full Text] [Related]

  • 20. Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
    Bladbjerg EM, Skouby SO, Andersen LF, Jespersen J.
    Hum Reprod; 2002 Dec 20; 17(12):3235-41. PubMed ID: 12456630
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.